Log in to save to my catalogue

Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personal...

Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personal...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2500380477

Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?

About this item

Full title

Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?

Publisher

England: BMJ Publishing Group LTD

Journal title

Gut, 2021-09, Vol.70 (9), p.1768-1781

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

Gastroenteropancreatic neuroendocrine neoplasia (GEPNEN) comprises clinically as well as prognostically diverse tumour entities often diagnosed at late stage. Current classification provides a uniform terminology and a Ki67-based grading system, thereby facilitating management. Advances in the study of genomic and epigenetic landscapes have amplifi...

Alternative Titles

Full title

Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2500380477

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2500380477

Other Identifiers

ISSN

0017-5749

E-ISSN

1468-3288

DOI

10.1136/gutjnl-2020-321300

How to access this item